D2 Fungal Sequencing Identification
Use
This test is intended for the identification of fungal organisms through sequencing. It plays a crucial role in the diagnosis and treatment of fungal infections by determining the specific fungal species present in a clinical sample. Accurate identification of the fungal pathogen can guide appropriate antifungal therapy, improving patient outcomes and helping to manage antifungal resistance.
Special Instructions
This test is designated for billing purposes only and is not directly orderable. Clients must consult their regional manager or customer service for detailed fee schedules and billing arrangements.
Limitations
This fungal sequencing test is not directly orderable and is primarily configured for billing arrangements. It may not be suitable for all types of fungal species and the sequencing process may not detect certain rare or highly divergent fungi. Additionally, the test cannot provide information on antifungal susceptibility, and results should be interpreted in conjunction with clinical findings and other laboratory tests.
New York Approved
Methodology
NGS
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Not provided
Minimum Volume
Not provided